Track the 이지바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Food & Beverage sector, 이지바이오 has logged 36 public disclosures. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: 이지홀딩스. All data is accessible without an account.
36
Insider Decl.
n/a
Thresholds
n/a
23 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.